Literature DB >> 23638812

Diagnostics for tuberculosis: what test developers want to know.

Madhukar Pai.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23638812     DOI： 10.1586/erm.13.16

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN： 1473-7159            Impact factor:   5.225


× No keyword cloud information.
  6 in total

1.  Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis.

Authors:  D W Dowdy; A van't Hoog; M Shah; F Cobelens
Journal:  Int J Tuberc Lung Dis       Date:  2014-06       Impact factor: 2.373

Review 2.  Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.

Authors:  Madhukar Pai; Marco Schito
Journal:  J Infect Dis       Date:  2015-04-01       Impact factor: 5.226

3.  Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling.

Authors:  D W Dowdy; R Houben; T Cohen; M Pai; F Cobelens; A Vassall; N A Menzies; G B Gomez; I Langley; S B Squire; R White
Journal:  Int J Tuberc Lung Dis       Date:  2014-09       Impact factor: 2.373

Review 4.  Exploring the Case for a Global Alliance for Medical Diagnostics Initiative.

Authors:  Melissa L Mugambi; Kara M Palamountain; Jim Gallarda; Paul K Drain
Journal:  Diagnostics (Basel)       Date:  2017-01-26

5.  How to implement new diagnostic products in low-resource settings: an end-to-end framework.

Authors:  Melissa Latigo Mugambi; Trevor Peter; Samuel F Martins; Cristina Giachetti
Journal:  BMJ Glob Health       Date:  2018-11-16

6.  Market assessment of tuberculosis diagnostics in Brazil in 2012.

Authors: 
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.